ESTRING 2 mg, drug release system vaginal sachet
Active ingredients: 17β-estradiol, Estradiol hemihydrate
Commercialized according to BDPMDispensing in France: Prescription only
Drug release systemsachetvaginale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ESTRING 2 mg, système de diffusion vaginal
- Pharmaceutical form
- système de diffusion
- Route of administration
- vaginale
- Presentation description
- 1 sachet(s) polytéréphtalate (PET) aluminium polyéthylène basse densité (PEBD) de 1 dispositif(s)
- Marketing authorisation holder
- PFIZER HOLDING FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 20 Sept 2016
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60535331CIP72756618CIP133400927566189Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ESTRADIOLsystème de diffusion | 1,94 mg · un anneau vaginal | FT |
| ESTRADIOL HÉMIHYDRATÉsystème de diffusion | 2 mg · un anneau vaginal | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.